Literature DB >> 25909419

Recombinant human brain natriuretic peptide ameliorates trauma-induced acute lung injury via inhibiting JAK/STAT signaling pathway in rats.

Zhi Song1, Xiu Zhao, Yan Gao, Martin Liu, Mingxiao Hou, Hongxu Jin, Yan Cui.   

Abstract

BACKGROUND: JAK/STAT signal pathway plays an important role in the inflammation process of acute lung injury (ALI). This study aimed to investigate the correlation between recombinant human brain natriuretic peptide (rhBNP) and the JAK/STAT signaling pathway and to explore the protective mechanism of rhBNP against trauma-induced ALI.
METHODS: The arterial partial pressure in oxygen, lung wet-dry weight ratios, protein content in bronchoalveolar lavage fluid, the histopathologic of the lung, as well as the protein expressions of STAT1, JAK2, and STAT3 were detected.
RESULTS: Sprague-Dawley rats were randomly divided into five groups: a control group, a sham-operated group, an ALI group, an ALI + rhBNP group, and an ALI + AG490 group. At 4 hours, 12 hours, 1 day, 3 days, and 7 days after injury, injured lung specimens were harvested. rhBNP pretreatment significantly ameliorated hypoxemia and histopathologic changes and alleviated pulmonary edema in trauma-induced ALI rats. rhBNP pretreatment reduced the phosphorylated protein and total protein level of STAT1. Similarly to JAK-specific inhibitor AG490, rhBNP was shown to significantly inhibit the phosphorylation of JAK2 and STAT3 in rats with trauma-induced ALI.
CONCLUSION: Our experimental findings indicated that rhBNP can protect rats against trauma-induced ALI and that its underlying mechanism may be related to the inhibition of JAK/STAT signaling pathway activation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25909419     DOI: 10.1097/TA.0000000000000602

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  10 in total

1.  Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Authors:  Jiping Zhao; Hao Yu; Yudong Liu; Sara A Gibson; Zhaoqi Yan; Xin Xu; Amit Gaggar; Pui-Kai Li; Chenglong Li; Shi Wei; Etty N Benveniste; Hongwei Qin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

2.  Propofol Protects Rats and Human Alveolar Epithelial Cells Against Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting HMGB1 Expression.

Authors:  Xiaoyan Wang; Chengxiao Liu; Gongming Wang
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

3.  Inhibition of Fibroblast Growth Factor Receptor by AZD4547 Protects Against Inflammation in Septic Mice.

Authors:  Yueyue Huang; Fen Wang; Hao Li; ShunYao Xu; Wenwei Xu; XiaoJun Pan; Yufeng Hu; Lingjie Mao; Songzan Qian; Jingye Pan
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

4.  Protective effect of pterostilbene on sepsis-induced acute lung injury in a rat model via the JAK2/STAT3 pathway.

Authors:  Hua Xue; Manxiang Li
Journal:  Ann Transl Med       Date:  2020-11

5.  Impaired Glucocorticoid Receptor Signaling Aggravates Lung Injury after Hemorrhagic Shock.

Authors:  Jonathan M Preuss; Ute Burret; Michael Gröger; Sandra Kress; Angelika Scheuerle; Peter Möller; Jan P Tuckermann; Martin Wepler; Sabine Vettorazzi
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

6.  Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.

Authors:  Yunpeng Luo; Wen Che; Mingyan Zhao
Journal:  Int J Mol Med       Date:  2016-12-13       Impact factor: 4.101

7.  An integrated network pharmacology and RNA-Seq approach for exploring the preventive effect of Lonicerae japonicae flos on LPS-induced acute lung injury.

Authors:  Chang Liu; Zhigang Yin; Tingting Feng; Min Zhang; Zhi Zhou; Ying Zhou
Journal:  J Ethnopharmacol       Date:  2020-09-09       Impact factor: 4.360

8.  Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury.

Authors:  Fengming Huang; Cong Zhang; Qiang Liu; Yan Zhao; Yuqing Zhang; Yuhao Qin; Xiao Li; Chang Li; Congzhao Zhou; Ningyi Jin; Chengyu Jiang
Journal:  PLoS Pathog       Date:  2020-03-16       Impact factor: 6.823

9.  Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury.

Authors:  Yafeng Liang; Jiaqi Luo; Nengli Yang; Shufen Wang; Mingwei Ye; Guoquan Pan
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

10.  The inhibition of miR‑101a‑3p alleviates H/R injury in H9C2 cells by regulating the JAK2/STAT3 pathway.

Authors:  Jingying Liu; Juanjuan Wang; Yuzhen Ning; Fengying Chen
Journal:  Mol Med Rep       Date:  2019-11-05       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.